WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Up 8% – Still a Buy?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s share price rose 8% on Monday . The stock traded as high as $9.13 and last traded at $9.09. Approximately 1,566 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 75,101 shares. The stock had previously closed at $8.42.

WuXi Biologics (Cayman) Stock Down 0.9%

The stock’s 50 day moving average price is $8.34 and its two-hundred day moving average price is $8.93.

About WuXi Biologics (Cayman)

(Get Free Report)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.

Read More

• Five stocks we like better than WuXi Biologics (Cayman)
• Short Squeeze Alert—Moderna Stock Surges on New Strategy
• NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
• Amazon Could Be About to Reap the Rewards of a Software Spending Boom
• Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof

Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.